VKORC1 Knockout HAP1 Cell Line

The choice depends on whether you are studying vitamin K cycle biology or modeling warfarin sensitivity/resistance phenotypes. The Knockout line is the standard tool for both — complete VKORC1 loss recapitulates vitamin K-dependent coagulation factor deficiency phenotypes seen in warfarin-treated individuals. Overexpression is useful for studying VKORC1 variant alleles associated with warfarin dose variability in pharmacogenomic research. For vitamin K cycle research and warfarin pharmacogenomics, the EDITGENE Knockout line in HAP1 is the more direct tool — the near-haploid background eliminates allelic complications relevant to dose-dependent warfarin responses observed in heterozygous patients. Rescue with wild-type or warfarin-resistant (e.g., Y139F) VKORC1 variants is particularly valuable for studying warfarin pharmacogenomics.

Primary applications: • Vitamin K cycle assays: measurement of vitamin K hydroquinone regeneration from vitamin K epoxide using HPLC-based detection. • Gamma-carboxylation activity: assessment of vitamin K-dependent protein gamma-carboxylation (e.g., Gla domain modification of coagulation factors). • Warfarin sensitivity studies: dose-response analysis for warfarin and other 4-hydroxycoumarin anticoagulants. • Variant allele studies: rescue with warfarin-resistant (e.g., Y139F, V66M) VKORC1 alleles for pharmacogenomic research. EDITGENE recommends this model for researchers investigating vitamin K biology, warfarin pharmacogenomics, and anticoagulant resistance mechanisms.

Yes. VKORC1 rescue experiments require attention to ER membrane topology and pharmacogenomic variant analysis: • Construct design: use a codon-modified VKORC1 sequence with a small C-terminal tag (FLAG, HA). VKORC1 is a multi-pass ER membrane protein — N-terminal tags can interfere with signal anchor function. • Warfarin-resistant mutant rescue: variants such as Y139F or V66M confer warfarin resistance and are critical tools for pharmacogenomic studies; rescue with these variants enables direct comparison of warfarin sensitivity. • Catalytic mutant rescue: cysteine mutations in the active site (e.g., C132S) abolish reductase activity and serve as enzymatic specificity controls. • Functional readout: rescue should restore vitamin K epoxide reductase activity (measured by HPLC) and warfarin sensitivity (measured by gamma-carboxylation of vitamin K-dependent proteins). HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.